When Nancy Greeley was in her 50s, her sister, an infectious-disease specialist at the University of Rochester, told her to ...
Children's Hospital of Michigan is treating the first person in Michigan with a newly approved gene-editing therapy for beta thalassemia.
Post-treatment Lyme disease syndrome (PTLDS) is a condition in which symptoms persist 6 months after the patient has received ...